<DOC>
	<DOCNO>NCT00314184</DOCNO>
	<brief_summary>This multicenter , randomize , parallel-group , double-blind , placebo-controlled study evaluate efficacy safety quetiapine lithium ( comparator study ) 104 week maintenance treatment adult patient Bipolar I Disorder . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Quetiapine Fumarate Bipolar Maintenance Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Signed informed consent 18 year old A diagnosis Bipolar I Disorder Have current manic , depress mixed episode Have manic , depress mixed episode last 26 week treat quetiapine Female patient childbearing potential must use reliable method contraception Pregnancy Substance alcohol dependence enrollment Unstable thyroid function Unstable Diabetes Unstable inadequately treat medical illness e.g. , angina pectoris hypertension Use experimental drug within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Bipolar I disorder .</keyword>
</DOC>